不同运动剂量对新诊断2型糖尿病患者胰岛β细胞功能的影响:DOSE-EX多臂平行组随机临床试验研究方案与依据
DOSE-EX试验为4臂评估者盲法随机对照试验,计划纳入80例新诊断2型糖尿病患者,随机分配至无干预、饮食干预、饮食干预联合中等量监督运动或饮食干预联合高量监督运动16周,主要结局为高血糖钳夹评估的晚期相处置指数变化。
要点
- 研究探讨不同运动量联合饮食干预对2型糖尿病β细胞功能的影响
- 主要结局采用高血糖钳夹评估的晚期相处置指数
- 纳入标准为确诊2型糖尿病不足7年
核心结论
- 该研究方案旨在评估不同运动训练量作为饮食治疗辅助手段对2型糖尿病患者胰岛β细胞功能的作用。
研究设计与样本
- 平行组、4臂评估者盲法随机临床试验,计划纳入80例2型糖尿病患者,按1:1:1:1随机分配(按性别分层)。
- 四组分别为无干预对照、饮食干预、饮食干预联合监督下中等量运动、饮食干预联合监督下高量运动,干预期16周。
- 主要结局为高血糖钳夹评估的晚期相处置指数从基线至随访的变化。
主要发现
- 该文为研究方案,未报告研究结果。
关键数值与推荐
- 纳入标准为2型糖尿病确诊不足7年的患者。
- 主要结局指标为晚期相处置指数(DI)变化,通过高血糖钳夹评估。
- 次要结局包括心血管代谢危险因素指标及与2型糖尿病相关后续并发症的影响。
临床怎么用
- 该方案为未来临床实践提供关于2型糖尿病患者运动训练量联合饮食干预改善β细胞功能所需剂量的证据基础。
- 研究结果有望阐明体力活动减轻2型糖尿病相关微血管和大血管并发症的机制。
局限性
- 原文未报告研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lifestyle intervention, i.e. diet and physical activity, forms the basis for care of type 2 diabetes (T2D). The current physical activity recommendation for T2D is aerobic training for 150 min/week of moderate to vigorous intensity, supplemented with resistance training 2-3 days/week, with no more than two consecutive days without physical activity. The rationale for the recommendations is based on studies showing a reduction in glycated haemoglobin (HbA1c). This reduction is supposed to be caused by increased insulin sensitivity in muscle and adipose tissue, whereas knowledge about effects on abnormalities in the liver and pancreas are scarce, with the majority of evidence stemming from in vitro and animal studies. The aim of this study is to investigate the role of the volume of exercise training as an adjunct to dietary therapy in order to improve the pancreatic β-cell function in T2D patients less than 7 years from diagnosis. The objective of this protocol for the DOSE-EX trial is to describe the scientific rationale in detail and to provide explicit information about study procedures and planned analyses. METHODS/DESIGN: In a parallel-group, 4-arm assessor-blinded randomised clinical trial, 80 patients with T2D will be randomly allocated (1:1:1:1, stratified by sex) to 16 weeks in either of the following groups: (1) no intervention (CON), (2) dietary intervention (DCON), (3) dietary intervention and supervised moderate volume exercise (MED), or (4) dietary intervention and supervised high volume exercise (HED). Enrolment was initiated December 15th, 2018, and will continue until N = 80 or December 1st, 2021. Primary outcome is pancreatic beta-cell function assessed as change in late-phase disposition index (DI) from baseline to follow-up assessed by hyperglycaemic clamp. Secondary outcomes include measures of cardiometabolic risk factors and the effect on subsequent complications related to T2D. The study was approved by The Scientific Ethical Committee at the Capital Region of Denmark (H-18038298). TRIAL REGISTRATION: The Effects of Different Doses of Exercise on Pancreatic β-cell Function in Patients With Newly Diagnosed Type 2 Diabetes (DOSE-EX), NCT03769883, registered 10 December 2018 https://clinicaltrials.gov/ct2/show/NCT03769883 ). Any modification to the protocol, study design, and changes in written participant information will be approved by The Scientific Ethical Committee at the Capital Region of Denmark before effectuation. DISCUSSION: The data from this study will add knowledge to which volume of exercise training in combination with a dietary intervention is needed to improve β-cell function in T2D. Secondarily, our results will elucidate mechanisms of physical activity mitigating the development of micro- and macrovascular complications correlated with T2D.
引用
- Lyngbaek MPP, Legaard GE, Bennetsen SL, et al. The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the "DOSE-EX" multi-arm parallel-group randomised clinical trial. Trials. 2021. PMID: 33794975. doi:10.1186/s13063-021-05207-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。